Skip to main content
SpringerLink
Log in

De rol van heparansulfaatproteoglycanen in de pathogenese van de ziekte van Alzheimer

  • Artikelen
  • Published:
Neuropraxis

Abstract

Mede door de ontwikkeling van antibiotica, uitgebalanceerde voeding en aandacht voor hygiëne is de gemiddelde levensverwachting in de twintigste eeuw drastisch gestegen. Als gevolg hiervan is ook de incidentie van leeftijdsgerelateerde aandoeningen, zoals de ziekte van Alzheimer, toegenomen. Verwacht wordt dat in Nederland tegen het midden van deze eeuw meer dan 300.000 patiënten aan de ziekte van Alzheimer zullen lijden.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1
2
3
4

Similar content being viewed by others

Literatuur

  • Bame, K.J., Danda, J., Hassall, A. & Tumova, S. (1997). Abeta(1-40) prevents heparanase-catalyzed degradation of heparan sulfate glycosaminoglycans and proteoglycans in vitro. A role for heparan sulfate proteoglycan turnover in Alzheimer's disease. J Biol Chem 272, 17005-17011.

    Google Scholar 

  • Bernfield, M., Gotte, M., Park, P.W., Reizes, O., Fitzgerald, M.L., Lincecum, J. & Zako, M. (1999). Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68, 729-777.

    Google Scholar 

  • Bernfield, M., Kokenyesi, R., Kato, M., Hinkes, M.T., Spring, J., Gallo, R.L. & Lose, E.J. (1992). Biology of the syndecans: a family of transmembrane heparan sulfate proteoglycans. Annu Rev Cell Biol 8, 365-393.

    Google Scholar 

  • Cotman, S.L., Halfter, W. & Cole, G.J. (2000). Agrin binds to beta-amyloïd (Abeta), accelerates abeta fibril formation, and is localized to Abeta deposits in Alzheimer's disease brain. Mol Cell Neurosci 15, 183-198.

    Google Scholar 

  • Dickson, D.W. (1997a). The pathogenesis of senile plaques. J Neuropathol Exp Neurol 56, 321-339.

    Google Scholar 

  • Dickson, D.W. (1997b). The pathogenesis of senile plaques. J Neuropathol Exp Neurol 56, 321-339.

    Google Scholar 

  • Dow, K.E. & Wang, W. (1998). Cell biology of astrocyte proteoglycans. Cell Mol Life Sci 54, 567-581.

    Google Scholar 

  • Fraser, P.E., Nguyen, J.T., Chin, D.T. & Kirschner, D.A. (1992). Effects of sulfate ions on Alzheimer beta/A4 peptide assemblies: implications for amyloïd fibril-proteoglycan interactions. J Neurochem 59, 1531-1540.

    Google Scholar 

  • Gervais, F., Chalifour, R., Garceau, D., Kong, X., Laurin, J., Mclaughlin, R., Morissette, C. & Paquette, J. (2001). Glycosaminoglycan mimetics: a therapeutic approach to cerebral amyloïd angiopathy. Amyloïd 8 Suppl 1, 28-35.

    Google Scholar 

  • Gupta, B.R., Frederickson, R.C.& Brunden, K.R. (1995). Proteoglycan-mediated inhibition of A beta proteolysis. A potential cause of senile plaque accumulation. J Biol Chem 270, 18666-18671.

    Google Scholar 

  • Iozzo, R.V. (2001b). Series Introduction: Heparan sulfate proteoglycans: intricate molecules with intriguing functions. J Clin Invest 108, 165-167.

    Google Scholar 

  • Iozzo, R.V. (2001a). Series Introduction: Heparan sulfate proteoglycans: intricate molecules with intriguing functions. J Clin Invest 108, 165-167.

    Google Scholar 

  • Kisilevsky, R., Lemieux, L.J., Fraser, P.E., Kong, X., Hultin, P.G. & Szarek, W.A. (1995). Arresting amyloïdosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease [see comments]. Nat Med 1, 143-148.

    Google Scholar 

  • Kisilevsky, R. & Szarek, W.A. (2002). Novel glycosaminoglycan precursors as anti-amyloïd agents part II. J Mol Neurosci 19, 45-50.

    Google Scholar 

  • Kisilevsky, R., Szarek, W.A., Ancsin, J., Bhat, S., Li, Z. & Marone, S. (2003). Novel Glycosaminoglycan Precursors as Anti-Amyloïd Agents, Part III. J Mol Neurosci 20, 291-298.

    Google Scholar 

  • Kisilevsky, R., Szarek, W.A., Ancsin, J., Vohra, R., Li, Z. & Marone, S. (2004). Novel glycosaminoglycan precursors as antiamyloïd agents: Part IV. J Mol Neurosci 24, 167-172.

    Google Scholar 

  • McLaurin, J., Franklin, T., Kuhns, W.J. & Fraser, P.E. (1999a). A sulfated proteoglycan aggregation factor mediates amyloïd-beta peptide fibril formation and neurotoxicity. Amyloïd 6, 233-243.

    Google Scholar 

  • McLaurin, J., Franklin, T., Zhang, X., Deng, J. & Fraser, P.E. (1999b). Interactions of Alzheimer amyloïd-beta peptides with glycosaminoglycans effects on fibril nucleation and growth. Eur J Biochem 266, 1101-1110.

    Google Scholar 

  • Miller, J.D., Cummings, J., Maresh, G.A., Walker, D.G., Castillo, G.M., Ngo, C., Kimata, K., Kinsella, M.G., Wight, T.N. & Snow, A.D. (1997). Localization of perlecan (or a perlecan-related macromolecule) to isolated microglia in vitro and to microglia/macrophages following infusion of beta-amyloïd protein into rodent hippocampus. Glia 21, 228-243.

    Google Scholar 

  • Selkoe, D. J. (1998). The cell biology of beta-amyloïd precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol 8, 447-453.

    Google Scholar 

  • Selkoe, D.J. (1991). The molecular pathology of Alzheimer's disease. Neuron 6, 487-498.

    Google Scholar 

  • Shaffer, L.M., Dority, M.D., Gupta-Bansal, R., Frederickson, R.C., Younkin, S.G. & Brunden, K.R. (1995). Amyloïd beta protein (A beta) removal by neuroglial cells in culture. Neurobiol Aging 16, 737-745.

    Google Scholar 

  • Snow, A.D., Mar, H., Nochlin, D., Kimata, K., Kato, M., Suzuki, S., Hassell, J. & Wight, T.N. (1988). The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am J Pathol 133, 456-463.

    Google Scholar 

  • Snow, A.D., Mar, H., Nochlin, D., Sekiguchi, R.T., Kimata, K., Koike, Y. & Wight, T.N. (1990a). Early accumulation of heparan sulfate in neurons and in the beta-amyloïd protein-containing lesions of Alzheimer's disease and Down's syndrome. Am J Pathol 137, 1253-1270.

    Google Scholar 

  • Snow, A.D., Mar, H., Nochlin, D., Sekiguchi, R.T., Kimata, K., Koike, Y., & Wight, T.N. (1990b). Early accumulation of heparan sulfate in neurons and in the beta-amyloïd protein-containing lesions of Alzheimer's disease and Down's syndrome. Am J Pathol 137, 1253-1270.

    Google Scholar 

  • Snow, A.D., Sekiguchi, R., Nochlin, D., Fraser, P., Kimata, K., Mizutani, A., Arai, M., Schreier, W.A. & Morgan, D.G. (1994). An important role of heparan sulfate proteoglycan (Perlecan) in a model system for the deposition and persistence of fibrillar A beta-amyloïd in rat brain. Neuron 12, 219-234.

    Google Scholar 

  • Snow, A.D. & Wight, T.N. (1989). Proteoglycans in the pathogenesis of Alzheimer's disease and other amyloïdoses. Neurobiol Aging 10, 481-497.

    Google Scholar 

  • Snow, A.D., Willmer, J.P. & Kisilevsky, R. (1987). Sulfated glycosaminoglycans in Alzheimer's disease. Hum Pathol 18, 506-510.

    Google Scholar 

  • Stoothoff, W.H. & Johnson, G.V. (2005). Tau phosphorylation: physiological and pathological consequences. Biochim Biophys Acta 1739, 280-297.

    Google Scholar 

  • Van Horssen, J., Kleinnijenhuis, J., Maass, C.N., Rensink, A.A., Otte-Holler, I., David, G., Van den Heuvel, L.P., Wesseling, P., De Waal, R.M. & Verbeek, M.M. (2002c). Accumulation of heparan sulfate proteoglycans in cerebellar senile plaques. Neurobiol Aging 23, 537-545.

    Google Scholar 

  • Van Horssen, J., Kleinnijenhuis, J., Maass, C.N., Rensink, A.A., Otte-Holler, I., David, G., Van den Heuvel, L.P., Wesseling, P., De Waal, R.M. & Verbeek, M.M. (2002b). Accumulation of heparan sulfate proteoglycans in cerebellar senile plaques. Neurobiol Aging 23, 537-545.

    Google Scholar 

  • Van Horssen, J., Kleinnijenhuis, J., Maass, C.N., Rensink, A.A., Otte-Holler, I., David, G., Van den Heuvel, L.P., Wesseling, P., De Waal, R.M. & Verbeek, M.M. (2002a).Accumulation of heparan sulfate proteoglycans in cerebellar senile plaques. Neurobiol Aging 23, 537-545.

  • Van Horssen, J., Otte-Holler, I., David, G., Maat-Schieman, M.L., Van den Heuvel, L.P., Wesseling, P., De Waal, R.M. & Verbeek, M.M. (2001). Heparan sulfate proteoglycan expression in cerebrovascular amyloïd beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloïdosis (Dutch) brains. Acta Neuropathol (Berl) 102, 604-614.

    Google Scholar 

  • Van Horssen, J., Wesseling, P., Van den Heuvel, L.P., De Waal, R.M. & Verbeek, M.M. (2003). Heparan sulphate proteoglycans in Alzheimer's disease and amyloïd-related disorders. Lancet Neurol 2, 482-492.

    Google Scholar 

  • Van Horssen, J., Wilhelmus, M. M., Heljasvaara, R., Pihlajaniemi, T., Wesseling, P., De Waal, R. M., and Verbeek, M. M. (2002d) Collagen XVIII: a novel heparan sulfate proteoglycan associated with vascular amyloïd depositions and senile plaques in Alzheimer's disease brains. Brain Pathol 12, 456-462.

  • Verbeek, M.M., Otte, H., I, van-den-Born, J., Van-den-Heuvel, L.P., David, G., Wesseling, P. & De Waal, R.M. (1999). Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain. Am J Pathol 155, 2115-2125.

  • Yang, D.S., Serpell, L.C., Yip, C.M., McLaurin, J., Chrishti, M.A., Horne, P., Boudreau, L., Kisilevsky, R., Westaway, D. & Fraser, P.E. (2001). Assembly of Alzheimer's amyloïd-beta fibrils and approaches for therapeutic intervention. Amyloïd 8 Suppl 1, 10-19.

    Google Scholar 

  • Zhu, H., Yu, J. & Kindy, M.S. (2001). Inhibition of amyloïdosis using low-molecular-weight heparins. Mol Med 7, 517-522.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dr. J. van Horssen, biomedicus, Afdeling Moleculaire celbiologie en Immunologie, Vrije Universiteit medisch centrum, Van der Boechorststraat 7, 1081, Amsterdam, BT

    Jack van Horssen

Authors
  1. Jack van Horssen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jack van Horssen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

van Horssen, J. De rol van heparansulfaatproteoglycanen in de pathogenese van de ziekte van Alzheimer. NEPR 9, 171–176 (2005). https://doi.org/10.1007/BF03079066

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03079066

Search

Navigation